SecBot SecBot
SC 13G ·Filed Oct 30, 2026

IDXX

IDEXX LABORATORIES INC /DE
NEUTRAL
Impact 3/10
Horizonimmediate Processed2d 4h ago SEC0002100121-26-001090
Passive investor 5%+ stake
Actionable Insight • Neutral

The filing reflects a routine index-fund driven increase above 5%. No activist intent. Monitor for any future 13D conversion, but none is indicated. The stake is consistent with Vanguard's passive investment strategy.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Vanguard Portfolio Management LLC filed a Schedule 13G disclosing a 5.04% passive stake in IDEXX Laboratories as of September 30, 2026. This is a new filing by this Vanguard entity, indicating a routine index-fund related position increase above the 5% threshold. The filing certifies passive intent with no control influence.

Key Financial Metrics

Stake
5.04%
Investor
Vanguard Portfolio Management LLC
Investor Type
mutual fund

Key Facts

  • Vanguard Portfolio Management LLC filed a new Schedule 13G for IDEXX Laboratories Inc.
  • Beneficial ownership: 3,974,472 shares of common stock, representing 5.04% of shares outstanding.
  • The filing is dated September 30, 2026 and was filed on October 30, 2026.
  • The filing certifies passive intent under Rule 13d-1(b) with no purpose of changing or influencing control.
  • This is a new filing by Vanguard Portfolio Management LLC; prior 13G filings for IDXX were by Vanguard Capital Management LLC and Vanguard Group Inc.

Financial Impact

Stake of 3,974,472 shares valued at approximately $2.2 billion based on $44.3B market cap and 5.04% ownership.

ownership_percentage

Risk Factors

  • No material risks identified; this is a routine passive disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
67% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0002100121-26-001090
Document: 0002100121-26-001090-index.html0002100121-26-001090
Document: 0002100121-26-001090.txt0002100121-26-001090
6 reports for IDXX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IDXX, sortable and filterable
TypeNow
Oct 30, 2026
2d ago
SC 13G
NEUTRAL ★ 3/10
$556.00awaiting T+60awaiting T+60$551.21 (−0.86%)
Oct 26, 2026
6d ago
Institutional Cluster
NEUTRAL ★ 3/10
$570.21awaiting T+60awaiting T+60$551.21 (−3.33%)
Oct 16, 2026
16d ago
Court Ruling
NEUTRAL ★ 2/10
$555.80awaiting T+60awaiting T+60$551.21 (−0.83%)
Aug 4, 2026
12w ago
8-K
BULLISH ★ 7/10
$588.09 $561.25▼ −4.56%▼ −4.35%$551.21 (−6.27%)
May 5, 2026
25w ago
8-K
BULLISH ★ 8/10
$560.55 $558.80▼ −0.31%▼ −2.79%$551.21 (−1.67%)
Mar 27, 2026
31w ago
DEFA14A
NEUTRAL ★ 2/10
$556.91 $549.16▼ −1.39%▼ −17.42%$551.21 (−1.02%)
Showing 6 of 6

US Market Status

Market Closed · Opens Mon (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026